Northern Trust
UNCY icon

Northern Trust’s Unicycive Therapeutics UNCY Stock Holding History

Northern Trust’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$853K Buy
181,930
+145,993
+406% +$1.08M ﹤0.01% 3527
2026
Q1 		$236K Hold
35,937
– – ﹤0.01% 3894
2025
Q4 		$207K Buy
35,937
+3,238
+10% +$17.3K ﹤0.01% 3978
2025
Q3 		$143K Buy
32,699
+21,912
+203% +$95.5K ﹤0.01% 4060
2025
Q2 		$51.5K Buy
10,787
+2
+0% +$12 ﹤0.01% 4229
2025
Q1 		$62K Buy
10,785
+4,967
+85% +$30.3K ﹤0.01% 4198
2024
Q4 		$46.2K Buy
5,818
+3,418
+142% +$18.9K ﹤0.01% 4265
2024
Q3 		$9.79K Hold
2,400
– – ﹤0.01% 4382
2024
Q2 		$12K Hold
2,400
– – ﹤0.01% 4366
2024
Q1 		$33.1K Buy
+2,400
New +$29.1K ﹤0.01% 4284

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.94% 1-Year Est. Return

Northern Trust's UNCY Position: Q2 2026 in Review

Northern Trust increased its Unicycive Therapeutics (UNCY) stake by 406% in Q2 2026, buying an estimated $1.08M and bringing the position to 181,930 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

Northern Trust first reported a position in UNCY in Q1 2024 and has held it in 10 quarters since. 73 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Northern Trust held 181,930 shares of Unicycive Therapeutics worth $853K as of Q2 2026.
  • Northern Trust bought 145,993 Unicycive Therapeutics shares in Q2 2026, an estimated $1.08M.
  • Unicycive Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3527 holding.
  • Northern Trust first reported a position in Unicycive Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 73 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.